Tuaminoheptane has been found to act as a [[reuptake inhibitor]] and [[releasing agent]] of [[norepinephrine]], which may underlie its decongestant and stimulant effects.<ref name="pmid2386550">{{cite journal | vauthors = Delicado EG, Fideu MD, Miras-Portugal MT, Pourrias B, Aunis D | title = Effect of tuamine, heptaminol and two analogues on uptake and release of catecholamines in cultured chromaffin cells | journal = Biochem. Pharmacol. | volume = 40 | issue = 4 | pages = 821–5 | year = 1990 | pmid = 2386550 | doi = | url = }}</ref><ref name="pmid21885739">{{cite journal | vauthors = Schlessinger A, Geier E, Fan H, Irwin JJ, Shoichet BK, Giacomini KM, Sali A | title = Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 108 | issue = 38 | pages = 15810–5 | year = 2011 | pmid = 21885739 | pmc = 3179104 | doi = 10.1073/pnas.1106030108 | url = }}</ref><ref name="pmid20122452" /> It is an [[Amine#Classes of amines|alkylamine]].<ref name="pmid20122452" /> The [[chemical structure]] of the drug differs from that of other [[norepinephrine releasing agent]]s, such as the [[substituted phenethylamine|phenethylamine]]s, which, in contrast to tuaminoheptane, have an [[aromatic ring]] in their structure.<ref name="pmid21885739" /> Tuaminoheptane is also a [[skin irritant]] and can cause [[contact dermatitis]] via [[channel blocker|inhibition]] of [[volume-regulated anion channel]]s, which limits its usefulness as a decongestant.<ref name="pmid17384225">{{cite journal | vauthors = Raoux M, Colomban C, Delmas P, Crest M | title = The amine-containing cutaneous irritant heptylamine inhibits the volume-regulated anion channel and mobilizes intracellular calcium in normal human epidermal keratinocytes | journal = Mol. Pharmacol. | volume = 71 | issue = 6 | pages = 1685–94 | year = 2007 | pmid = 17384225 | doi = 10.1124/mol.106.033324 | url = }}</ref>
